Human medicines European public assessment report (EPAR): Daxas, roflumilast, Date of authorisation: 05/07/2010, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Daxas, roflumilast, Date of authorisation: 05/07/2010, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Tepadina, thiotepa, Date of authorisation: 15/03/2010, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Tepadina, thiotepa, Date of authorisation: 15/03/2010, Revision: 23, Status: Authorised

Q&A on impact of EU-USA Mutual Recognition Agreement on marketing authorisation applications and relevant variations - Revised 1st October 2025

Q&A on impact of EU-USA Mutual Recognition Agreement on marketing authorisation applications and relevant variations - Revised 1st October 2025

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness